Daiwa SB Investments’s Biogen BIIB Stock Holding History

Daiwa SB Investments’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,040	Closed	-$251K	–	215
2016 Q2	$251K	Sell	1,040 -5,480	-84%	-$1.44M	0.07%	90
2016 Q1	$1.7M	Buy	6,520 +708	+12%	+$187K	0.43%	44
2015 Q4	$1.78M	Sell	5,812 -1,257	-18%	-$361K	0.42%	49
2015 Q3	$2.06M	Sell	7,069 -171	-2%	-$56.5K	0.47%	49
2015 Q2	$2.92M	Sell	7,240 -2,720	-27%	-$1.09M	0.57%	45
2015 Q1	$4.21M	Buy	9,960 +4,042	+68%	+$1.59M	0.75%	43
2014 Q4	$2.01M	Sell	5,918 -2,884	-33%	-$933K	0.32%	61
2014 Q3	$2.91M	Buy	+8,802	New	+$2.9M	0.36%	74
2014 Q2	–	Sell	-10,210	Closed	-$3.12M	–	120
2014 Q1	$3.12M	Buy	+10,210	New	+$3.24M	0.37%	66
2013 Q4	–	Sell	-13,263	Closed	-$3.19M	–	142
2013 Q3	$3.19M	Sell	13,263 -1,710	-11%	-$383K	0.36%	46
2013 Q2	$3.22M	Buy	+14,973	New	+$3.2M	0.55%	47

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Daiwa SB Investments's BIIB Position: Q3 2016 in Review

Daiwa SB Investments sold out of Biogen (BIIB) in Q3 2016, closing a stake of 1,040 shares — an estimated $251K sold.

Daiwa SB Investments first reported a position in BIIB in Q2 2013 and held it in 11 quarters. The position peaked at $4.21M in Q1 2015. 1,012 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

Daiwa SB Investments reported no remaining Biogen position as of Q3 2016 after selling out during the quarter.
Daiwa SB Investments sold 1,040 Biogen shares in Q3 2016, an estimated $251K.
Daiwa SB Investments first reported a position in Biogen in Q2 2013 and held it in 11 quarters.
Daiwa SB Investments's Biogen position peaked at $4.21M in Q1 2015.
1,012 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Daiwa SB Investments's 13F filing for Q3 2016, filed 12 Oct 2016.